AZD2624 Multiple Ascending Dose Study in Japan

NCT00696865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Safety

Interventions

DRUG: AZD2624
DRUG: Placebo

Sponsor

AstraZeneca